Type 2 Diabetes Mellitus in Patient Safety, Preventive & Ethics — 45yo Man | Ethics | SMLE Q#11731
SMLE Question #11731
Patient Safety, Preventive & Ethics
Ethics
Objective: OBJ-243
Last updated: February 2026
A 45-year-old man with type 2 diabetes mellitus is enrolled in a randomized clinical trial of a new oral antihyperglycemic medication. After several weeks on the study drug, he develops hypoglycemia with confusion and is treated urgently in the emergency department. The principal investigator is concerned that stopping the drug may affect study outcomes and statistical power. What is the most appropriate action by the researcher now?
Continue in practice mode
Sign in and start a focused practice session to view options, submit your answer, and read the full explanation.